Delivery Order SPE2DB22D1202-SPE2DB25FURC7
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 200 mg/100 mL solution, a local anesthetic medication. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical...
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $6,539.27, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.86, is for the delivery of 400 mg/200 mL of Ropivacaine 0.2% solution. It is a firm fixed-price delivery order contract with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery...
This federal contract award, valued at $8,218.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 400 mg/200 ml vials of the anesthetic drug Ropivacaine 0.2%, with a period of performance through April 19, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, worth $3,217.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of 4565732573 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a specialty medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of September 10, 2024 and is a Firm Fixed Price Delivery Order. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Ropivacaine 0.2% 200 mg/100 mL, a local anesthetic medication, with a ceiling value of $1,029.75 and an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to...
This is a federal delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 400 mg/200 ml vials of the anesthetic medication Ropivacaine 0.2%. The delivery order is valued at $3,650.13 and is a firm fixed-price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,851.72, is for the supply of 400 mg/200 mL of Ropivacaine 0.2% in a 200 mL dosage. The delivery order was awarded on May 16, 2023, with a completion date of May 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, for the delivery of 4564014130 - Ropivacaine 0.2% 400 mg/200 ml, a specialty brand name medication. The award, valued at $7,621.52, is a firm fixed price delivery order with a completion date of March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...